Exchange Bulletin

Appili Therapeutics Inc. (APLI) To Trade On Toronto Stock Exchange

September 14, 2020
Issuer: Appili Therapeutics Inc. ("Appili")
Security: Class A common shares (the "Common Shares")
Symbol: APLI
Number of securities issued and outstanding: 61,604,011 Common Shares
Number of securities reserved for issuance: 25,330,929 Common Shares
Listing category: Industrial, Non-Exempt Issuer
Trading currency: CDN$
Listing and posted for trading date: September 16, 2020 (at the opening)
Other market(s): The Common Shares have been listed on TSX Venture Exchange ("TSXV") since June 25, 2019 under the symbol "APLI". The Common Shares will be delisted from TSXV on September 16, 2020, upon commencement of trading on Toronto Stock Exchange.
Temporary market maker: Canaccord Genuity Corp.
Security ownership registration: Certificated Issue & Direct Registration System
Investor relations: Ms. Kimberly Stephens
(902) 442-4655, ext. 2

Mr. Armand Balboni
(902) 442-4655, ext. 1
Incorporation: Canada Business Corporations Act
Fiscal year end: March 31
Nature of business: Appili is a pharmaceutical company focused on the acquisition and development of novel medicines targeting unmet needs in infectious disease. Since incorporation in 2015, Appili has been focused on building and advancing a diverse portfolio of anti-infective programs.
Transfer agent and registrar: Computershare Investor Services Inc. at its principal offices in Montréal and Toronto
Dividends: Appili does not expect to declare dividends in the foreseeable future.
Sponsorship: Not applicable
TSX contact: Chris Birkett,
Managing Director,
Toronto Stock Exchange